quinazolines has been researched along with nsc 352122 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Groot, R; Neijens, HJ; Smit, MJ; Van der Voort, E; Van Dongen, JJ; Whitfield, LR | 1 |
Donehower, RC; Ettinger, DS; Grochow, LB; Noe, DA | 1 |
Nightingale, SL; Young, FE | 1 |
Dole, GB; Donehower, RC; Ettinger, DS; Graham, ML; Grochow, LB; McGuire, WP; Noe, DA; Rowinsky, EK | 1 |
6 other study(ies) available for quinazolines and nsc 352122
Article | Year |
---|---|
Trimetrexate efficacy and pharmacokinetics during treatment of refractory Pneumocystis carinii pneumonia in an infant with severe combined immunodeficiency disease.
Topics: Antifungal Agents; Drug Combinations; Glucuronates; Humans; Immunologic Deficiency Syndromes; Infant; Infusions, Intravenous; Leucovorin; Male; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Respiratory Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1990 |
AIDS drug available.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Glucuronates; Humans; Pneumonia, Pneumocystis; Quinazolines; Trimetrexate | 1988 |
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Female; Glucuronates; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Quinazolines; Time Factors; Trimetrexate | 1989 |
FDA's newly designated treatment INDs.
Topics: Clinical Protocols; Cytomegalovirus; Cytomegalovirus Infections; Drug Combinations; Drug Therapy, Combination; Glucuronates; Humans; Immune Sera; Immunoglobulins; Immunoglobulins, Intravenous; Kidney Transplantation; Leucovorin; Pneumonia, Pneumocystis; Quinazolines; Trimetrexate; United States; United States Food and Drug Administration | 1988 |
Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.
Topics: Adult; Aged; Animals; Bone Marrow; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Female; Glucuronates; Humans; Male; Mice; Middle Aged; Neoplasms; Quinazolines; Skin; Species Specificity; Trimetrexate | 1989 |
FDA bends rules on experimental AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Glucuronates; Health Policy; Humans; Public Health; Quinazolines; Trimetrexate; United States; United States Food and Drug Administration | 1988 |